Cargando…

Characterization of FGFR signaling pathway as therapeutic targets for sarcoma patients

The fibroblast growth factor receptor (FGFR) family plays important roles in regulating cell growth, proliferation, survival, differentiation and angiogenesis. Deregulation of the FGF/FGFR signaling pathway has been associated with multiple development syndromes and cancers, and thus therapeutic str...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Wen-Ya, Zheng, Hong, Du, Xiao-Ling, Yang, Ji-Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chinese Anti-Cancer Association 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944539/ https://www.ncbi.nlm.nih.gov/pubmed/27458533 http://dx.doi.org/10.20892/j.issn.2095-3941.2015.0102

Ejemplares similares

Targetable Pathways in Advanced Bladder Cancer: FGFR Signaling
por: Xiao, Jin-Fen, et al.
Publicado: (2021)

Targeting the FGFR signaling pathway in cholangiocarcinoma: promise or delusion?
por: Wang, Jing, et al.
Publicado: (2020)

Current progress in cancer treatment by targeting FGFR signaling
por: Du, Sicheng, et al.
Publicado: (2023)

FGF/FGFR signaling pathway involved resistance in various cancer types
por: Zhou, Yangyang, et al.
Publicado: (2020)

Fibroblast Growth Factor Receptor (FGFR) Signaling in GIST and Soft Tissue Sarcomas
por: Napolitano, Andrea, et al.
Publicado: (2021)

Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma
por: Borad, Mitesh J., et al.
Publicado: (2014)

FGFR Signaling as a Candidate Therapeutic Target for Cancers Resistant to Carbon Ion Radiotherapy
por: Darwis, Narisa Dewi Maulany, et al.
Publicado: (2019)

FGFR1 is a potential therapeutic target in neuroblastoma
por: Cimmino, Flora, et al.
Publicado: (2022)

Deciphering role of FGFR signalling pathway in pancreatic cancer
por: Kang, Xiaodiao, et al.
Publicado: (2019)

Targeting FGF19/FGFR4 Pathway: A Novel Therapeutic Strategy for Hepatocellular Carcinoma
por: Repana, Dimitra, et al.
Publicado: (2015)

FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma
por: Tamburello, Mariangela, et al.
Publicado: (2022)

Targeting the Src Pathway Enhances the Efficacy of Selective FGFR Inhibitors in Urothelial Cancers with FGFR3 Alterations
por: Lima, Nadia Carvalho, et al.
Publicado: (2020)

Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab
por: Zecchetto, Camilla, et al.
Publicado: (2023)

Inhibitive Effects of FGF2/FGFR1 Pathway on Astrocyte-Mediated Inflammation in vivo and in vitro After Infrasound Exposure
por: Shi, Ya-Jun, et al.
Publicado: (2018)

Signaling Pathway and Small-Molecule Drug Discovery of FGFR: A Comprehensive Review
por: Zheng, Jia, et al.
Publicado: (2022)

Targeting FGFR Pathways in Gastrointestinal Cancers: New Frontiers of Treatment
por: Ratti, Margherita, et al.
Publicado: (2023)

The Function of FGFR1 Signalling in the Spinal Cord: Therapeutic Approaches Using FGFR1 Ligands after Spinal Cord Injury
por: Haenzi, Barbara, et al.
Publicado: (2017)

Inhibition of FGFR Signaling by Targeting FGF/FGFR Extracellular Interactions: Towards the Comprehension of the Molecular Mechanism through NMR Approaches
por: Pagano, Katiuscia, et al.
Publicado: (2022)

Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment
por: Ruan, Ruiwen, et al.
Publicado: (2023)

FGF/FGFR Signaling in Hepatocellular Carcinoma: From Carcinogenesis to Recent Therapeutic Intervention
por: Wang, Yijun, et al.
Publicado: (2021)

Intrinsic FGFR2 and Ectopic FGFR1 Signaling in the Prostate and Prostate Cancer
por: Wang, Cong, et al.
Publicado: (2019)

FGF/FGFR signaling in health and disease
por: Xie, Yangli, et al.
Publicado: (2020)

FGFR Pathway Inhibition in Gastric Cancer: The Golden Era of an Old Target?
por: Lengyel, Csongor G., et al.
Publicado: (2022)

Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targets
por: Kim, Jihyun, et al.
Publicado: (2018)

Targeting FGFR in non-small cell lung cancer: implications from the landscape of clinically actionable aberrations of FGFR kinases
por: Zhou, Zhen, et al.
Publicado: (2021)

FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy
por: Quintanal-Villalonga, Álvaro, et al.
Publicado: (2020)

Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer
por: Weickhardt, Andrew J., et al.
Publicado: (2022)

DJ-1/FGFR-1 Signaling Pathway Contributes to Sorafenib Resistance in Hepatocellular Carcinoma
por: Chen, Xin, et al.
Publicado: (2022)

The Role of TGF-β Signaling Pathways in Cancer and Its Potential as a Therapeutic Target
por: Yang, Yun, et al.
Publicado: (2021)

FGFR1 regulates proliferation and metastasis by targeting CCND1 in FGFR1 amplified lung cancer
por: Yang, Ying, et al.
Publicado: (2020)

ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer
por: di Martino, Erica, et al.
Publicado: (2019)

Crosstalk between SHH and FGFR Signaling Pathways Controls Tissue Invasion in Medulloblastoma
por: Neve, Anuja, et al.
Publicado: (2019)

FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells
por: Yuan, Hong, et al.
Publicado: (2017)

Targeting local lymphatics to ameliorate heterotopic ossification via FGFR3-BMPR1a pathway
por: Zhang, Dali, et al.
Publicado: (2021)

FGFR2 alteration as a potential therapeutic target in poorly cohesive gastric carcinoma
por: Wang, Yue, et al.
Publicado: (2021)

miR-628 reduces prostate cancer proliferation and invasion via the FGFR2 signaling pathway
por: Chen, Jun, et al.
Publicado: (2019)

FOXO Signaling Pathways as Therapeutic Targets in Cancer
por: Farhan, Mohd, et al.
Publicado: (2017)

Prospective Clinical Genomic Profiling of Ewing Sarcoma: ERF and FGFR1 Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance
por: Ogura, Koichi, et al.
Publicado: (2022)

MiR‐3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway
por: Kong, Shiqi, et al.
Publicado: (2020)

FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growth in vitro
por: Künstlinger, Helen, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qmkg1igpddjhrk17vh8ptfb27m